Clinical Trials Logo

Clinical Trial Summary

A single-arm, open-labeled, single-center, descriptive and exploratory safety trial using ADSC-SVF-002. ADSC-SVF-002 is an autologous adipose derived stem cell (ADSC)-containing stromal vascular fraction (SVF) obtained from subcutaneous fat harvested by liposuction from a patient. As a cellular therapy product, ADSC-SVF-002 (fresh or cryopreserved) will be administered subcutaneously via injection, with or without unprocessed autologous fat (fresh or cryopreserved), into soft tissue defects and abnormally healing wounds. The primary objective of the trial is to demonstrate the safety of ADSC-SVF-002 in a population of subjects with soft tissue defects or abnormal wound healing who are still symptomatic despite being managed by conventional therapies.


Clinical Trial Description

Protocol Number: SJS-CT-001 Phase: Pilot study Methodology: Open label, single-arm Study Duration: Six months after accrual and treatment of the last patient Study Center(s): Single-center Objectives: To demonstrate the safety of subcutaneous administration of autologous ADSC-SVF-002 in a population of subjects with soft tissue defects or abnormal wound healing who are still symptomatic despite being managed by conventional therapies.

Number of Subjects: 10 Diagnosis and Main Inclusion Criteria: Subject has soft tissue deficiencies, soft tissue post traumatic malformations, scars, and/or abnormal wound healing.

Study Product, Dose, Route, Regimen: ADSC-SVF-002. 1.0x106 cells/mL defect (when administered without fat) to 1.2x106 cells/mL defect (when administered with fat). Subcutaneous injection.

Duration of administration: Administration of the product takes approximately 30 minutes. Administered once.

Reference therapy: N/A

Statistical Methodology: Safety outcomes will be reported with descriptive statistics. Secondary (efficacy) outcomes will be assessed relative to baseline (screening) as follows:

- For outcomes assessed at multiple follow-up visits, one-way ANOVAs followed by the Tukey's test will be conducted

- For outcomes assessed at one follow-up visit, a Student's t-test will be conducted.

Data will be reported as mean ± SD and p<0.05 will be considered significant. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02590042
Study type Interventional
Source AdiSave Inc.
Contact Keren Leibson, PhD
Phone 416 785-7536
Email info@adisave.com
Status Not yet recruiting
Phase Phase 1
Start date October 2017
Completion date January 2021

See also
  Status Clinical Trial Phase
Completed NCT04806594 - Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar. N/A
Completed NCT01700595 - Preexpanded Perforator Flaps in Children N/A
Recruiting NCT03782038 - Study to Evaluate the Efficacy of a Micro Coring Device for the Treatment of Scars of the Cytrellis Micro-Coring Device for the Treatment of Scars N/A
Recruiting NCT06202274 - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology N/A
Completed NCT01932359 - Rapidly Absorbable Versus Non-absorbable Sutures for Mohs Surgery Repair on the Face: a Randomized Controlled Split-scar Study N/A
Unknown status NCT00969475 - The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure N/A
Completed NCT01091181 - The Effect of Hysterotomy Technique on the Rate of Large Defects in the Hysterotomy Scar N/A
Recruiting NCT06021275 - Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars N/A
Recruiting NCT02195063 - Survey Study for Pain Management, Wound Care, Scar Care or UDT Phase 4
Terminated NCT00803140 - Cutaneous Scarring of Scalpel Versus Cautery N/A
Not yet recruiting NCT04593706 - Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars) N/A
Recruiting NCT05847530 - Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions N/A
Withdrawn NCT01350739 - The Umbilical Access in Laparoscopic Surgery N/A
Completed NCT02145130 - Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects Phase 1
Completed NCT01358838 - Ablative 10600 nm Fractional Laser Therapy for the Treatment of Scars N/A
Completed NCT03880058 - Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance Phase 1/Phase 2
Recruiting NCT05528328 - Post-surgical Scars After the Use of CACIPLIQ20 Phase 3
Completed NCT00450775 - Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars Phase 4
Completed NCT00580736 - Optical Clearing of the Skin in Conjunction With Laser Treatments Phase 1
Withdrawn NCT04269317 - Clinical Study to Evaluate the Safety and Effectiveness of the Treatment With Tixel C on Acne Scars N/A